{"id":"https://openalex.org/W2050309563","doi":"https://doi.org/10.2337/diacare.14.8.724","title":"Dose-Dependent Effects of Glyburide on Insulin Secretion and Glucose Uptake in Humans","display_name":"Dose-Dependent Effects of Glyburide on Insulin Secretion and Glucose Uptake in Humans","alternate_titles":[],"publication_year":1991,"publication_date":"1991-08-01","ids":{"openalex":"https://openalex.org/W2050309563","doi":"https://doi.org/10.2337/diacare.14.8.724","mag":"2050309563","pmid":"https://pubmed.ncbi.nlm.nih.gov/1954808"},"language":"en","primary_location":{"id":"doi:10.2337/diacare.14.8.724","doi":"https://doi.org/10.2337/diacare.14.8.724","is_oa":false,"landing_page_url":"https://doi.org/10.2337/diacare.14.8.724","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2050309563"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074771810","display_name":"Leif Groop","orcid":"https://orcid.org/0000-0002-0187-3263","observed_orcids":["https://orcid.org/0000-0002-0187-3263"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]},{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI","SE","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Leif C Groop","raw_affiliation_strings":["Fourth Department of Medicine, Helsinki University Hospital\u2008Helsinki, Finland; the Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio\u2008San Antonio, Texas; and the Department of Clinical Pharmacology, University of Lund\u2008Lund/Malm\u00f6, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fourth Department of Medicine, Helsinki University Hospital\u2008Helsinki, Finland; the Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio\u2008San Antonio, Texas; and the Department of Clinical Pharmacology, University of Lund\u2008Lund/Malm\u00f6, Sweden","institution_ids":["https://openalex.org/I165951966","https://openalex.org/I187531555","https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055979731","display_name":"Nir Barzilai","orcid":"https://orcid.org/0000-0002-7787-6268","observed_orcids":["https://orcid.org/0000-0002-7787-6268"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]},{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI","SE","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nir Barzilai","raw_affiliation_strings":["Fourth Department of Medicine, Helsinki University Hospital\u2008Helsinki, Finland; the Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio\u2008San Antonio, Texas; and the Department of Clinical Pharmacology, University of Lund\u2008Lund/Malm\u00f6, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fourth Department of Medicine, Helsinki University Hospital\u2008Helsinki, Finland; the Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio\u2008San Antonio, Texas; and the Department of Clinical Pharmacology, University of Lund\u2008Lund/Malm\u00f6, Sweden","institution_ids":["https://openalex.org/I165951966","https://openalex.org/I187531555","https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108392066","display_name":"Klaus Ratheiser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]},{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI","SE","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Klaus Ratheiser","raw_affiliation_strings":["Fourth Department of Medicine, Helsinki University Hospital\u2008Helsinki, Finland; the Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio\u2008San Antonio, Texas; and the Department of Clinical Pharmacology, University of Lund\u2008Lund/Malm\u00f6, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fourth Department of Medicine, Helsinki University Hospital\u2008Helsinki, Finland; the Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio\u2008San Antonio, Texas; and the Department of Clinical Pharmacology, University of Lund\u2008Lund/Malm\u00f6, Sweden","institution_ids":["https://openalex.org/I165951966","https://openalex.org/I187531555","https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072631239","display_name":"Livio Luzi","orcid":"https://orcid.org/0000-0003-3183-0552","observed_orcids":["https://orcid.org/0000-0003-3183-0552"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]},{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI","SE","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Livio Luzi","raw_affiliation_strings":["Fourth Department of Medicine, Helsinki University Hospital\u2008Helsinki, Finland; the Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio\u2008San Antonio, Texas; and the Department of Clinical Pharmacology, University of Lund\u2008Lund/Malm\u00f6, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fourth Department of Medicine, Helsinki University Hospital\u2008Helsinki, Finland; the Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio\u2008San Antonio, Texas; and the Department of Clinical Pharmacology, University of Lund\u2008Lund/Malm\u00f6, Sweden","institution_ids":["https://openalex.org/I165951966","https://openalex.org/I187531555","https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021611610","display_name":"E Wahlin\u2010Boll","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]},{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI","SE","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elisabeth W\u00e5hlin-Boll","raw_affiliation_strings":["Fourth Department of Medicine, Helsinki University Hospital\u2008Helsinki, Finland; the Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio\u2008San Antonio, Texas; and the Department of Clinical Pharmacology, University of Lund\u2008Lund/Malm\u00f6, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fourth Department of Medicine, Helsinki University Hospital\u2008Helsinki, Finland; the Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio\u2008San Antonio, Texas; and the Department of Clinical Pharmacology, University of Lund\u2008Lund/Malm\u00f6, Sweden","institution_ids":["https://openalex.org/I165951966","https://openalex.org/I187531555","https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109282871","display_name":"Arne Melander","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]},{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI","SE","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Arne Melander","raw_affiliation_strings":["Fourth Department of Medicine, Helsinki University Hospital\u2008Helsinki, Finland; the Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio\u2008San Antonio, Texas; and the Department of Clinical Pharmacology, University of Lund\u2008Lund/Malm\u00f6, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fourth Department of Medicine, Helsinki University Hospital\u2008Helsinki, Finland; the Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio\u2008San Antonio, Texas; and the Department of Clinical Pharmacology, University of Lund\u2008Lund/Malm\u00f6, Sweden","institution_ids":["https://openalex.org/I165951966","https://openalex.org/I187531555","https://openalex.org/I2800394112"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091912602","display_name":"Ralph A. DeFronzo","orcid":"https://orcid.org/0000-0003-3839-1724","observed_orcids":["https://orcid.org/0000-0003-3839-1724"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]},{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI","SE","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ralph A DeFronzo","raw_affiliation_strings":["Fourth Department of Medicine, Helsinki University Hospital\u2008Helsinki, Finland; the Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio\u2008San Antonio, Texas; and the Department of Clinical Pharmacology, University of Lund\u2008Lund/Malm\u00f6, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fourth Department of Medicine, Helsinki University Hospital\u2008Helsinki, Finland; the Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio\u2008San Antonio, Texas; and the Department of Clinical Pharmacology, University of Lund\u2008Lund/Malm\u00f6, Sweden","institution_ids":["https://openalex.org/I165951966","https://openalex.org/I187531555","https://openalex.org/I2800394112"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7951,"has_fulltext":false,"cited_by_count":78,"citation_normalized_percentile":{"value":0.82710006,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"14","issue":"8","first_page":"724","last_page":"727"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.5702999830245972,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.5702999830245972,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.420199990272522,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":1.0},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9670000076293945},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.9559999704360962},{"id":"https://openalex.org/keywords/glucose-uptake","display_name":"glucose uptake","score":0.9729999899864197},{"id":"https://openalex.org/keywords/glucose-disposal","display_name":"glucose disposal","score":0.6899999976158142},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.7879999876022339},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.8230000138282776},{"id":"https://openalex.org/keywords/normoglycemia","display_name":"normoglycemia","score":0.8199999928474426},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/continuous-intravenous-infusion","display_name":"continuous intravenous infusion","score":0.6700000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8607414960861206},{"id":"https://openalex.org/C2778854520","wikidata":"https://www.wikidata.org/wiki/Q418776","display_name":"Sulfonylurea","level":3,"score":0.8533239960670471},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7697954177856445},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7365366220474243},{"id":"https://openalex.org/C2779768347","wikidata":"https://www.wikidata.org/wiki/Q420626","display_name":"Glibenclamide","level":3,"score":0.7292786240577698},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6700885891914368},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5648550391197205},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5542683005332947},{"id":"https://openalex.org/C3020574416","wikidata":"https://www.wikidata.org/wiki/Q275157","display_name":"Plasma glucose","level":3,"score":0.5241318345069885},{"id":"https://openalex.org/C17093226","wikidata":"https://www.wikidata.org/wiki/Q2734081","display_name":"Carbohydrate metabolism","level":2,"score":0.48676061630249023},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.461561381816864},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.45687639713287354},{"id":"https://openalex.org/C49039625","wikidata":"https://www.wikidata.org/wiki/Q84230","display_name":"Secretion","level":2,"score":0.41749411821365356},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.26495635509490967}],"mesh":[{"descriptor_ui":"D000078790","descriptor_name":"Insulin Secretion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015309","descriptor_name":"Glucose Clamp Technique","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2337/diacare.14.8.724","doi":"https://doi.org/10.2337/diacare.14.8.724","is_oa":false,"landing_page_url":"https://doi.org/10.2337/diacare.14.8.724","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmid:1954808","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1954808","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1270333399","display_name":null,"funder_award_id":"RR 125","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G2073161740","display_name":null,"funder_award_id":"F05-TWO-3451","funder_id":"https://openalex.org/F4320337356","funder_display_name":"Fogarty International Center"},{"id":"https://openalex.org/G3187800885","display_name":"REGULATION OF HEPATIC AND PERIPHERAL GLUCOSE METABOLISM","funder_award_id":"R01AM024092","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337356","display_name":"Fogarty International Center","ror":"https://ror.org/02xey9a22"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"},{"id":"https://openalex.org/F4320337376","display_name":"NIH Clinical Center","ror":"https://ror.org/04vfsmv21"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1973327823","https://openalex.org/W2015953629","https://openalex.org/W2143125641","https://openalex.org/W2030866252","https://openalex.org/W2004296097","https://openalex.org/W2008083814","https://openalex.org/W406455397","https://openalex.org/W2128911147","https://openalex.org/W2127744068","https://openalex.org/W2093425348"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"examine":[2],"the":[3,18,46,122,130],"relationship":[4],"between":[5],"plasma":[6,49,109],"glyburide":[7,50,67,98],"concentrations":[8,51,110],"(0,":[9],"50,":[10],"100,":[11],"200,":[12],"400,":[13],"and":[14,17,21,30,65,71],"800":[15],"nM)":[16],"insulin":[19,69],"response":[20],"glucose":[22,72],"metabolism":[23],"during":[24],"euglycemic":[25],"(4.6":[26],"+/-":[27,33],"0.1":[28],"mM)":[29,35],"hyperglycemic":[31],"(11.6":[32],"0.2":[34],"conditions.":[36],"RESEARCH":[37],"DESIGN":[38],"AND":[39],"METHODS:":[40],"Nine":[41],"healthy":[42],"subjects":[43],"participated":[44],"in":[45,136],"study.":[47],"Steady-state":[48],"were":[52],"achieved":[53,116,140],"by":[54],"primed":[55],"continuous":[56],"intravenous":[57],"infusion":[58],"of":[59,78,108,121,132],"glyburide.":[60],"RESULTS:":[61],"During":[62],"both":[63],"euglycemia":[64],"hyperglycemia,":[66],"enhanced":[68],"secretion":[70],"disposal":[73],"only":[74],"to":[75,82,90,126],"drug":[76],"levels":[77],"100-200":[79],"nM":[80],"corresponding":[81],"an":[83],"oral":[84],"dose":[85],"less":[86],"than":[87,145],"or":[88],"equal":[89],"10":[91],"mg.":[92],"CONCLUSIONS:":[93],"The":[94],"data":[95],"suggest":[96],"that":[97,146],"(and":[99],"probably":[100],"other":[101],"sulfonylureas),":[102],"operates":[103],"within":[104],"a":[105],"narrow":[106],"range":[107],"(50-200":[111],"nM),":[112],"which":[113],"can":[114],"be":[115,127],"with":[117,141],"very":[118],"low":[119],"doses":[120,144],"drug.":[123],"It":[124],"remains":[125],"shown":[128],"whether":[129],"threshold":[131],"maximal":[133],"effect":[134],"also":[135],"clinical":[137],"practice":[138],"is":[139],"lower":[142],"sulfonylurea":[143],"currently":[147],"used.":[148]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2050309563","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":6},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
